Ormat Technologies Form 144: $738k insider share sale slated for June 2025

Rhea-AI Filing Summary

Ormat Technologies, Inc. (ORA) has filed a Form 144 notice with the SEC indicating an insider’s intent to sell 8,548 shares of common stock.

The proposed sale, to be executed through Morgan Stanley Smith Barney LLC on the NYSE around 24 June 2025, carries an aggregate market value of $737,760.78. Based on the company’s 60,662,626 shares outstanding, the transaction represents roughly 0.014 % of total shares, implying minimal dilution.

The shares stem from equity-based compensation awards granted between May 2022 and March 2025, including restricted stock and performance shares. The filing shows no sales by the same insider during the past three months, and the seller certifies that no undisclosed material adverse information is known.

The identity and role of the seller are not provided in the filing, limiting insight into potential signaling effects. Nevertheless, Form 144 filings can sometimes influence sentiment because they reveal insider monetization plans, even when the amount is immaterial in percentage terms.

Positive

• None.

Negative

• Insider plans to sell 8,548 ORA shares worth $738k, which may be perceived as a confidence drag despite representing only 0.014 % of shares outstanding.

Insights

Financial Analyst

TL;DR: Very small (0.014 %) insider sale planned; neutral fundamental impact.

The 8,548-share sale is equivalent to one-seventh of one-tenth of a percent of ORA’s float. Such a negligible fraction neither affects liquidity nor alters ownership structure in any meaningful way. The shares arise from routine equity compensation, and no concurrent disposition history exists. Accordingly, I view the filing as informational rather than value-changing. Unless larger, repeated sales follow, the event should not influence valuation models or earnings projections.

Corporate Governance Specialist

TL;DR: Insider intends to monetize recent awards; mildly negative optics but immaterial.

Form 144 transparency is positive, yet insider selling—even small—can be read as a soft signal on future expectations. The lack of seller identity prevents investors from gauging significance (e.g., CEO vs. lower-level officer). Still, sub-$1 million sales seldom raise governance alarms. I classify the impact as a minor negative in perception only; corporate governance risk remains unchanged.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	8548	737760.78	60662626	06/24/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/01/2025	Restricted Stock	Issuer			1592	03/01/2025	Not Applicable
Common	05/12/2023	Performance Shares	Issuer			1230	05/12/2023	Not Applicable
Common	03/21/2024	Restricted Stock	Issuer			625	03/21/2024	Not Applicable
Common	03/01/2024	Restricted Stock	Issuer			357	03/01/2024	Not Applicable
Common	03/01/2025	Performance Shares	Issuer			1667	03/01/2025	Not Applicable
Common	05/12/2023	Restricted Stock	Issuer			698	05/12/2023	Not Applicable
Common	05/12/2022	Restricted Stock	Issuer			1396	05/12/2022	Not Applicable
Common	03/21/2025	Restricted Stock	Issuer			625	03/21/2025	Not Applicable
Common	03/01/2023	Restricted Stock	Issuer			358	03/01/2023	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

How many Ormat Technologies (ORA) shares are being sold under this Form 144?

The filing covers 8,548 shares of ORA common stock.

What is the approximate market value of the shares in the ORA Form 144 filing?

The aggregate market value disclosed is $737,760.78.

When is the planned sale date for the ORA shares?

The filer lists an approximate sale date of 24 June 2025.

What percentage of Ormat Technologies’ outstanding shares does the sale represent?

It represents about 0.014 % of the 60,662,626 shares outstanding.

Which broker will execute the proposed ORA share sale?

The broker named is Morgan Stanley Smith Barney LLC.